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The fine article, “First Attack of Acute Urticaria in a Pediatric Emergency Department” 
by Liu et al, which appeared in the June issue of Pediatrics and Neonatology prompted 
me to submit comments and a review on the subject of urticaria in children, because 
this is indeed a pediatric problem that is frequently seen in clinical practice.
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Infection as a Cause of Urticaria
The authors listed infection as the major cause of 
acute urticaria in younger patients. Indeed, as shown 
by Liu et al1 in Table 1, the category “infections” 
was the leading cause of urticaria (48.4%). Although 
the authors did not list of microorganisms involved, 
several microorganisms are known to be related to 
the development of acute urticaria. For example, 
viral exanthems are well known to cause urticaria.2−4 
In one earlier study, nearly 30% of cases of acute urti-
caria in children were considered to be the result of 
viral infection.2 In another study, hepatitis A, B and 
C, adenoviruses, and enteroviruses were mentioned 
as causative agents.3 Another study showed that as 
many as 79.5% of pediatric cases of acute urticaria 
were related to viral infection.4 In that study, iso-
lation confirmed cytomegalovirus, herpes simplex 
1 and influenza A in some patients, and serology 
confirmed infection with enterovirus, parvovirus B19, 
Epstein-Barr and mycoplasma in other patients.4
In addition, a common bacterium that is well 
known to cause urticaria rash in children should 
not be ignored, namely Group A beta hemolytic 
Streptococcus. Acute urticaria was reported to occur 
in 13 of 32 cases (40.6%) of patients infected with 
this microorganism.5 Documenting streptococcal 
infection is important, because it is treatable and 
the rash may occur again in the future. Another ex-
ample of a treatable infection that is known to 
cause acute urticaria in children is Mycoplasma 
pneumoniae.4,6
Infection, Antibiotics and Rash
The distinction between urticaria caused by infection 
and that induced by a drug reaction is clinically 
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unclear. Confirmation of infection re quires either 
isolation of the organism or a serological study. Both 
laboratory procedures are time-consuming and may 
not be practical in clinical practice. We have re-
ported cases of children with skin rashes (some in 
the form of urticaria) related to the use of antibi-
otic suspensions.7 After negative skin tests and oral 
challenges, we concluded that the majority of the 
cases were not the result of drug sensitivity, but 
rather were more likely to be the result of adverse 
reactions to excipients (dyes, flavorings or preserv-
atives). This conclusion was based on the fact that 
all of the patients tolerated excipient-free antibi-
otic suspensions without adverse reactions.7 In some 
of these patients, we had an opportunity to compare 
the plasma levels of glutathione during the time 
the rash was fresh and after it had resolved. We 
found that more than two-thirds of the patients 
had significantly lower glutathione levels during 
the time they had an active rash. This suggests to 
us that these patients might have had a transient 
lack of anti-oxidant activity during a time of stress. 
Additives have also been re cently reported as a 
cause of urticaria.8
Other Cause of Urticaria
One more cause of acute urticaria in children that 
is not mentioned in the study by Liu et al, but which 
has been reported elsewhere, is a reaction that oc-
curs in response to the use of contrast media. For 
example, Dillman et al9 studied a total of 11,306 
intravenous administrations of low-osmolarity, non-
ionic, iodinated contrast media in pediatric patients. 
Acute, allergic-like reactions (many with urticaria) 
were observed in 20 (0.18%) patients. Most of the re-
actions to contrast media are mild; however, severe 
reactions do occur.9
Hospitalization of the Patients
The admission rate cited in this report for patients 
with a first acute urticaria seems very high (30.8%). 
Although there are no published data available for 
comparison, our own hospital records at Shands 
Hos pital at the University of Florida show this rate 
to be much lower (3%). In our hospital, the indica-
tions for admission for acute urticaria are: (1) urti-
caria accompanied by either respiratory distress 
such as wheezing or stridor, or; (2) other signs of ana-
phylactic reaction, such as loss of consciousness, 
cardiovascular collapse, or severe gastrointestinal 
symptoms. We do not feel that skin manifestation 
alone is a reason for admission whether it is a first 
case or not.
Suggested Medical Approach for 
Patients with First Urticaria
First, good history taking is essential to determine 
if the rash is indeed due to an allergic reaction, 
because urticaria may be the first manifestation of 
anaphylaxis. Any history of food allergies and re-
cent ingest ion (particularly exposure to milk, eggs, 
fish or shellfish, peanuts and tree nuts) should be ob-
tained. History of drug allergies and ingestion should 
also be obtained. Although it is rare (based on this 
study), the history of allergies to and occurrences 
of insect stings, bites or exposure to latex should 
also be obtained. If the patient has developed urti-
caria during a study with contrast media, the radiol-
ogy department should be consulted.
Second, a quick physical examination should be 
performed to confirm that the patient does not show 
changes or deterioration of vital signs (pulse, heart 
and respiratory rates, and blood pressure). If the 
patient has other underlying diseases such as renal 
or hepatic disorders, appropriate laboratory tests 
should be ordered.
Third, based on this study, routine laboratory 
tests including complete blood cell counts with 
white cell differential, urine tests and blood bio-
chemistry are not informative. These should only 
be ordered at the clinician’s discretion. If a patient 
presents with a sore throat, testing for Streptococcus 
or Mycoplasma infection would be useful as a guide 
for antibiotic treatment.
Fourth, the initial approach for the treatment 
of acute urticaria is the immediate removal of the 
offending factor (such as a food or drug). Any under-
lying medical condition(s), such as infection, should 
be treated with antibiotics. As indicated above, 
Streptococcus or Mycoplasma infection should be 
treated accordingly.
Treatment of Acute Urticaria
An H1 antihistamine such as diphenhydramine 
(Benadryl) should be given at once. It is preferable 
to use the liquid or rapid-dissolving tablet form 
with their rapid onset of action, because a capsule 
may take much longer to achieve an effective 
blood level. H2 histamine blockers have also been 
recommended for the treatment of anaphylactic 
reactions, but their use in cases of acute urticaria 
has not been studied.
A dose of epinephrine will resolve urticaria quickly 
but, because of its short half-life, a second dose may 
be required.
If the urticaria does not fade within 2 hours, or if 
other symptoms develop, it is advisable to add an oral 
corticosteroid (prednisone at a dose of 1 mg/kg/day) 
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in an undivided dose for a total of 5 days. Lengthy 
treatment with corticosteroids should be accom-
panied by a warning about possible side effects.
It is interesting to note that in a recent survey,10 
general emergency room physicians were 2.6 times 
more likely to use H2 antagonists and more than 
three times as likely to use corticosteroids to treat 
severe urticaria then primary care physicians. It is 
unclear why there are such distinctive differences 
in the approach to treating these patients.
Follow-up
If the rash is the only manifestation and if the pa-
tient has stable vital signs for at least 2 hours, the 
patient may be released. A brief follow-up in 3 
days is advisable to confirm that the treatment 
was successful. 
As stated above, the mere manifestation of an 
urticarial rash is not a sufficient indication for hos-
pitalization. Hospital admission should be limited to 
those patients who develop anaphylactic reactions 
or other symptoms in addition to urticaria. I believe 
that this criterion is prudent for both primary care 
and for emergency department physicians.
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